Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0000898432-25-000785 0001745437 XXXXXXXX LIVE 5 Class A Common Stock, par value $0.01 12/31/2025 false 0001723128 03168L105 Amneal Pharmaceuticals, Inc. 400 Crossing Blvd Bridgewater NJ 08807 Christine Krentz (908) 409-6700 4 Gatehall Drive Parsippany NJ 07054 0001745437 Patel Dipan a OO X1 16904263 0 16904263 0 16904263 N 5.4 IN The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 314,629,101 shares of Class A Common Stock outstanding, as disclosed in the New Issuer's Annual Report on Form 10-K, filed on February 27, 2026. Class A Common Stock, par value $0.01 Amneal Pharmaceuticals, Inc. 400 Crossing Blvd Bridgewater NJ 08807 This Amendment No. 5 to Schedule 13D (this "Amendment No. 5") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 5, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the New Issuer. Capitalized terms used but not defined in this Amendment No. 5 shall have the meanings set forth in the Schedule 13D. Between November 14, 2024 and December 31, 2025, trusts controlled by the Reporting Person sold 6,924,729 shares of Class A Common Stock in open market transactions at prices per share between $7.74 and $12.42. The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Class A Common Stock as to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 314,629,101 shares of Class A Common Stock outstanding, as disclosed in the New Issuer's Annual Report on Form 10-K, filed on February 27, 2026: Reporting Person - Dipan Patel Amount Beneficially Owned - 16,904,263 Percent of Class - 5.4 Sole power to vote or to direct the vote - 16,904,263 Shared power to vote or to direct the vote - 0 Sole power to dispose or to direct the disposition - 16,904,263 Shared power to dispose or to direct the disposition - 0 The Reporting Person may be deemed to beneficially own 16,904,263 shares of Class A Common Stock held of record by trusts controlled by the Reporting Person. The information set forth in Item 4 of this Amendment No. 5 is incorporated by reference herein. None. Not applicable. Patel Dipan Dipan Patel Patel Dipan 03/26/2026